These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 21882108)

  • 1. Development of paediatric medicines: concepts and principles.
    Rose K; Della Pasqua O
    Handb Exp Pharmacol; 2011; 205():111-24. PubMed ID: 21882108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy assessment in paediatric studies.
    Wang S; Laitinen-Parkkonen P
    Handb Exp Pharmacol; 2011; 205():149-68. PubMed ID: 21882110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Historical development of pediatric pharmacology.
    Seyberth HW; Rane A; Schwab M
    Handb Exp Pharmacol; 2011; 205():v-vi. PubMed ID: 22046631
    [No Abstract]   [Full Text] [Related]  

  • 4. Off licence and off label prescribing in children: litigation fears for physicians.
    Hill P
    Arch Dis Child; 2005 Feb; 90 Suppl 1(Suppl 1):i17-8. PubMed ID: 15665151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changing requirements for evaluation of pharmacologic agents.
    Chesney RW; Christensen ML
    Pediatrics; 2004 Apr; 113(4 Suppl):1128-32. PubMed ID: 15060209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medicines for children licensed by the European Agency for the Evaluation of Medicinal Products.
    Ceci A; Felisi M; Catapano M; Baiardi P; Cipollina L; Ravera S; Bagnulo S; Reggio S; Rondini G
    Eur J Clin Pharmacol; 2002 Nov; 58(8):495-500. PubMed ID: 12451425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric regulatory initiatives.
    Hirschfeld S; Saint-Raymond A
    Handb Exp Pharmacol; 2011; 205():245-68. PubMed ID: 21882115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Criteria supporting the study of drugs in the newborn.
    Ward RM; Benitz WE; Benjamin DK; Blackmon L; Giacoia GP; Hudak M; Lasky T; Rodriguez W; Selen A
    Clin Ther; 2006 Sep; 28(9):1385-98. PubMed ID: 17062311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. European Union pediatric legislation jeopardizes worldwide, timely future advances in the care of children with cancer.
    Rose K
    Clin Ther; 2014 Feb; 36(2):163-77. PubMed ID: 24529288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Future developments of clinical research in pediatrics: the role of the Journal Klinische Pädiatrie.
    Körholz D; Gortner L; Göbel U
    Klin Padiatr; 2013 Jul; 225(4):191-2. PubMed ID: 23904155
    [No Abstract]   [Full Text] [Related]  

  • 11. Developing paediatric medicines: identifying the needs and recognizing the challenges.
    Ernest TB; Elder DP; Martini LG; Roberts M; Ford JL
    J Pharm Pharmacol; 2007 Aug; 59(8):1043-55. PubMed ID: 17725846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical programs in the development of similar biotherapeutic products: rationale and general principles.
    Berghout A
    Biologicals; 2011 Sep; 39(5):293-6. PubMed ID: 21911300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study design and simulation approach.
    Läer S; Meibohm B
    Handb Exp Pharmacol; 2011; 205():125-48. PubMed ID: 21882109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of medicines for children in Europe: ethical implications.
    Saint Raymond A; Brasseur D
    Paediatr Respir Rev; 2005 Mar; 6(1):45-51. PubMed ID: 15698816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The economics of pediatric formulation development for off-patent drugs.
    Milne CP; Bruss JB
    Clin Ther; 2008 Nov; 30(11):2133-45. PubMed ID: 19108801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Family pediatrics: report of the Task Force on the Family.
    Schor EL;
    Pediatrics; 2003 Jun; 111(6 Pt 2):1541-71. PubMed ID: 12777595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are development times for pharmaceuticals increasing or decreasing?
    Keyhani S; Diener-West M; Powe N
    Health Aff (Millwood); 2006; 25(2):461-8. PubMed ID: 16522587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postmarketing surveillance.
    Vlahović-Palčevski V; Mentzer D
    Handb Exp Pharmacol; 2011; 205():339-51. PubMed ID: 21882120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testing medications in children.
    Steinbrook R
    N Engl J Med; 2002 Oct; 347(18):1462-70. PubMed ID: 12409558
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug development process for a product with a primary pediatric indication.
    Allen AJ; Michelson D
    J Clin Psychiatry; 2002; 63 Suppl 12():44-9. PubMed ID: 12562061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.